Could the Polymorphisms of DOCK4 (rs147636134), SYNGAP1 (rs199759879), and FOXP1 (rs767001715) be the Primary Risk Factors for Bipolar Disorder and Autism Spectrum Disorder?

Scientists looked at specific DNA changes in three genes to see if they increase the risk of autism or bipolar disorder. They studied 200 people from Turkey - 50 with autism, 50 with bipolar disorder, and 100 without either condition. They found no significant differences in these genetic changes between the groups, suggesting these particular DNA variants may not be major risk factors for autism in this population. However, the study was small and more research is needed.

This genetic study examined whether specific DNA variants in three genes (FOXP1, SYNGAP1, and DOCK4) are associated with autism spectrum disorder (ASD) and bipolar disorder in 200 Turkish participants (50 ASD patients, 50 bipolar patients, 100 controls). These genes are important for brain development and synaptic function. The researchers used real-time PCR to analyze genetic polymorphisms and compared frequencies between groups. No statistically significant differences were found between patient groups and healthy controls for any of the examined variants.

The study suggests these particular genetic variants may not be primary risk factors for ASD or bipolar disorder in this population, though larger studies are needed.

These findings suggest the examined genetic variants may not be useful as biomarkers for ASD risk assessment in clinical practice. However, given the small sample size and population-specific nature, genetic testing decisions should not be based solely on these results.

Small sample size (50 ASD patients) limits generalizability of findings. Results cannot be extrapolated beyond the Turkish population studied. Authors acknowledge need for larger studies and functional analyses to better understand gene-disease associations.

Autism spectrum disorder (ASD) and bipolar disorder (BD) are psychiatric diseases that may overlap in common neurodevelopmental and genetic basis. Forkhead Box P1 (FOXP1), Synaptic Ras GTPase-activating protein 1 (SYNGAP1), and Dedicator of Cytokinesis 4 (DOCK4) genes are critical for synaptic plasticity, neuronal communication, and brain development. This study aims to investigate the association of FOXP1 (rs767001715), SYNGAP1 (rs199759879), and DOCK4 (rs147636134) polymorphisms with ASD and BD and to determine the effects of genetic variations on disease pathogenesis in the Turkish population. This study was conducted with a total of 200 participants, including 50 ASD patients, 50 BD patients, and 100 healthy controls.

DNA was isolated from peripheral blood samples, and FOXP1, SYNGAP1, and DOCK4 polymorphisms were genotyped using real-time PCR. The distribution of genetic variants was compared between patient groups and healthy controls. The chi-square test was applied for statistical analyses. In terms of FOXP1 (rs767001715), SYNGAP1 (rs199759879), and DOCK4 (rs147636134) polymorphisms examined in the study, no statistically significant difference was found between the ASD and BD patient groups and the healthy control group (p > 0.05) in the Turkish population.

In addition, it was determined that these variants had allele frequencies compatible with global population data. However, due to the limited sample size, these results cannot be generalized. Further large-scale population analyses and functional studies are needed to investigate the association of these genes with ASD and BD in more detail.